Monday, July 22

In 2022, F. Hoffmann-La Roche Ltd. (Switzerland) received FDA approval for the cobras EZH2 mutation test as a companion diagnostic for patients with follicular lymphomaNorthbrook, IL 60062 — (SBWIRE) — 11/29/2022 — Hemato Oncology Testing Market is projected to reach USD 5.6 billion by 2027 from an estimated USD 2.9 Billion in 2022…
Read More

Comments are closed.